Elsevier

Molecular Brain Research

Volume 110, Issue 1, 31 January 2003, Pages 7-14
Molecular Brain Research

Research report
Estrogen receptor β (ERβ) protein levels in neurons depend on estrogen receptor α (ERα) gene expression and on its ligand in a brain region-specific manner

https://doi.org/10.1016/S0169-328X(02)00544-2Get rights and content

Abstract

Estrogen receptors (ERs) α and β are very similar estrogen-binding proteins, perhaps gene duplication products, which act as ligand-dependent transcription factors. While the estrogenic regulation of ERα has been well documented, little is known about how estrogen regulates ERβ and whether ERα plays a role in the expression and estrogenic regulation of ERβ. In the present study, we examined the effects of gonadectomy and estrogen replacement on ERβ immunoreactivity (ir) in wild-type (WT) and ERα knockout (αERKO) adult male mice in six brain regions, the medial preoptic area (MPOA), the bed nucleus of the stria terminalis (BNST), the paraventricular nucleus (PVN), the ventromedial nucleus of hypothalamus (VMH), the medial amygdala nucleus (MeAMY) and the dorsal raphe nucleus (DRN). Mice were divided into four different treatment groups: gonadally intact, gonadectomized (GDX), GDX+short-term treatment with estrogen (s.c. injection of estradiol benzoate (EB), 5 μg, at 48 h before perfusion) or GDX+long-term treatment with estrogen (implant of an EB pellet, 2.5 μg/day, for 10 days). In intact αERKO mice, the number of ERβ expressing cells was significantly decreased in the MPOA and increased in the BNST, compared to WT mice. Both in the MPOA and BNST, steroid hormone regulation of ERβ protein (an increase by GDX and a decline to intact levels by EB) was found only in WT, not in αERKO mice. In the VMH, GDX significantly increased the number of ERβ ir expressing cells in both genotypes. EB treatment tended to decrease the number of ERβ ir cells in WT mice, whereas EB treatment tended to increase ERβ ir cell counts in αERKO mice. No effects of GDX or EB treatment were found in the DRN and MeAMY regardless of genotype. These results suggest that gonadal steroid hormones may regulate ERβ protein in male mice and ERα may be involved in the expression and regulation of ERβ in a region-specific manner.

Introduction

It has been well established that testosterone plays a major role in the expression of male typical sexual and aggressive behaviors. Testosterone exerts its function in the central nervous system (CNS) not only by acting through androgen receptors (AR), in its original form or as the 5α-reduced metabolite, dihydrotestosterone, but also by acting through estrogen receptors (ER), after being aromatized to estradiol (E2). Two subtypes of ERs, ERα and ERβ, which bind to E2 with a similar affinity, are identified in the CNS [13], [14], [37], [38]. ERα and β are very similar estrogen-binding proteins, perhaps gene duplication products, which can act as ligand-dependent transcription factors. Several lines of evidence have demonstrated that ER-dependent mechanisms as well as AR-dependent mechanisms may be involved in the regulation of reproductive and aggressive behaviors in male mice [23], [28], [34], [35]. It has not been studied until recently, however, how two types of ERs are involved in these behavioral regulations.

Behavioral studies using single (αERKO and βERKO) or double knockout (αβERKO) mice of ER genes suggest that both types of ERs are indeed involved in the regulation of a number of behaviors in male mice [17], [18], [19], [20], [21], [22]. These studies also showed that the lack of ERα and/or ERβ had differential effects on various behaviors. For instance, male sexual behavior was reduced in αERKO mice [18], [19], but not in βERKO mice [20], while it was completely abolished in αβERKO mice [21]. Male aggression, on the other hand, was greatly reduced in both αERKO and αβERKO mice [18], [19], [21], but increased in βERKO mice [17], [20]. Furthermore, facilitation of running wheel activity by estrogen was completely abolished in αERKO, but not in βERKO mice [22]. These findings support the notion that the two subtypes of ERs may be either synergistically or antagonistically involved in the regulation of brain function and behavior. It is not completely understood, however, how these two receptor systems affect each other’s message and protein expression in different parts of the brain.

Gonadal steroids regulate ERα mRNA and protein in a tissue-specific manner. In general, they are up-regulated by removal of gonadal steroids (gonadectomy) and down-regulated by estrogen replacement in the brain regions such as the medial preoptic area (MPOA), the bed nucleus of the stria terminalis (BNST), the ventromedial nucleus of hypothalamus (VMH), and arcuate nucleus [6], [10], [12], [16], [24], [29], [33], [39], although a different sensitivity of ERα regulation was observed depending on the sex, species, and steroid treatment regimens (e.g. short-term vs. long-term). In the medial amygdala (MeAMY), on the other hand, gonadectomy (GDX) and estrogen treatment do not affect ERα mRNA and protein [16], [24].

Very little is known about how estrogen regulates ERβ protein in the CNS and whether ERα plays a role in the expression of ERβ protein and its regulation by estrogen. Using RNase protection assay, it was shown that there were no differences in ERβ mRNA in hypothalamic tissues between αERKO and WT mice [4]. As this assay was carried out on RNA extracted from whole hypothalamic tissues, we cannot rule out the possibility that the expression of ERβ mRNA and protein in specific brain regions is indeed affected by the lack of ERα gene. Furthermore, it is not known whether the lack of ERα in αERKO mouse brain may affect the regulation of ERβ protein levels by estrogen.

In the present study, therefore, we compared the effects of GDX and short-term or long-term treatment of estrogen on ERβ immunoreactivity (ir) in αERKO and WT male mouse brains. We examined ERβ ir in six different brain regions where previous studies have shown that ERβ mRNA and immunoreactive cells are widely distributed [1], [3], [15], [29], [30], [31], [32]. Those included the MPOA, the BNST, the paraventricular nucleus (PVN), the VMH, the MeAMY and the dorsal raphe nucleus (DRN). It should be noted that distributions of ERα and ERβ are known to overlap in the MPOA and the BNST [30] whereas those in the DRN are quite distinctive [2], [3].

Section snippets

Mice

Adult (9–14 weeks old) male αERKO mice and their WT littermates were used. They were obtained from the αERKO breeding colonies maintained at the Rockefeller University by mating heterozygous male and female mice. Original breeding pairs (mixed background of C57BL/6J and 129) were obtained from the National Institute of Environmental Health Sciences. All procedures were approved by IACUC. Mice were group-housed (4–5 mice/cage) in plastic cages (30×20×12 cm) at constant temperature (22 °C) on a

Results

In both WT and αERKO mice, ERβ ir was localized in the nucleus of the neurons in all six brain regions examined. No apparent ERβ ir was observed in the cytoplasm or processes of the neurons.

In the MPOA, there was a significant genotype difference in the number of ERβ ir expressing cells in intact mice (P<0.01; Fig. 1, Fig. 4 and Table 1). αERKO intact mice showed a significantly lower number of ERβ ir expressing cells in the MPOA, compared to WT mice. In the MPOA of WT mice, GDX increased the

Site-specific effects of gonadectomy and estrogen treatment on the levels of ERβ immunoreactivity in WT mouse brains

We found in the present study that gonadectomy and estrogen treatment, site-specifically, affected the number of ERβ ir expressing cells in WT mouse brains. In the brain regions such as the MPOA, BNST and VMH, the numbers of ERβ ir cells were increased by gonadectomy in comparison to the gonadally intact mouse levels, and decreased by estrogen treatment (Table 1). We also found that the duration of exposure to ligand made a difference in the regulation of ERβ protein in WT mice. For instance,

Acknowledgements

Support for this work was provided by NIMH 62147 to SO. MN was a recipient of postdoctoral fellowships for research abroad from the Japan Society for Promotion of Science.

References (39)

  • K.B.J. Franklin et al.

    The Mouse Brain in Stereotaxic Coordinates

    (1997)
  • B. Gréco et al.

    Coexpression of ERβ with ERα and progestin receptor proteins in the female rat forebrain: effects of estradiol treatment

    Endocrinology

    (2001)
  • J.M. Hall et al.

    The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens

    Endocrinology

    (1999)
  • I. Kallo et al.

    Oestrogen receptor β-immunoreactivity in gonadotropin releasing hormone-expressing neurons: Regulation by oestrogen

    J. Neuroendocrinol.

    (2001)
  • M. Koch

    Effects of treatment with estradiol and parental experience on the number and distribution of estrogen-binding neurons in the ovariectomized mouse brain

    Neuroendocrinology

    (1990)
  • G.C. Kuiper et al.

    Cloning of a novel estrogen receptor expressed in rat prostate and ovary

    Proc. Natl. Acad. Sci. USA

    (1996)
  • G.C. Kuiper et al.

    Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β

    Endocrinology

    (1997)
  • N. Laflamme et al.

    Expression and neuropeptidergic characterization of estrogen receptors (ERα and ERβ) throughout the rat brain: anatomical evidence of distinct roles of each subtype

    J. Neurobiol.

    (1998)
  • A.H. Lauber et al.

    Estrogen receptor messenger RNA expression in rat hypothalamus as a function of genetic sex and estrogen dose

    Endocrinology

    (1991)
  • Cited by (0)

    View full text